Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,980.00    5.00 (0.25%)
Bid:
1,960.00
Ask:
1,985.00
Spread: 25.00 (1.276%)
Market Cap: £240.59m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Director/PDMR Shareholding

30 Mar 2011 07:00

RNS Number : 8626D
S & U PLC
30 March 2011
 



30 March 2011

S & U PLC ("S&U" or "the Company")

 Director/PDMR Shareholding

 

S & U were advised yesterday that its Chairman Anthony Coombs, has yesterday transferred in a buy/sell transaction 3000 Ordinary Shares into his Pension Fund.

Following this transaction his beneficial interests in the Ordinary Shares of the company remain unchanged.

 

 

 For further information, please contact:

 

S&U plc www.suplc.co.uk 

Anthony Coombs, Chairman 0121 705 7777

 

Broker and Financial Adviser

Adrian Trimmings/Jamie Cameron Arden Partners 0207 614 5920

 

Media and Investor Relations

Will Swan / Rebecca Whitehead Smithfield 020 7360 4900

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQKLFLFXFXBBE
Date   Source Headline
16th Apr 20215:37 pmRNSDirector/PDMR Shareholding and Total Voting Rights
14th Apr 20219:54 amRNSDirectorate Change
9th Apr 20217:00 amEQSEdison Investment Research Limited: S&U (SUS): Ready to meet unlocked demand
30th Mar 20217:00 amRNSPreliminary Results
18th Mar 20217:00 amRNSInvestor Presentation
11th Feb 202110:00 amRNSCORRECTION: TRADING STATEMENT & NOTICE OF RESULTS
11th Feb 20217:00 amRNSTrading Statement and Notice of Results
27th Jan 20213:40 pmRNSDirector/PDMR Shareholding
9th Dec 20204:35 pmRNSPrice Monitoring Extension
9th Dec 20207:00 amRNSTrading Statement
23rd Nov 20209:55 amRNSBlock Listing Six Monthly Return
30th Sep 20207:01 amRNSDirectorate Change
30th Sep 20207:00 amRNSInterim Results
24th Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSNotice of Results
28th Aug 20203:36 pmRNSHolding(s) in Company
28th Aug 20203:35 pmRNSHolding(s) in Company
11th Aug 20207:00 amRNSTRADING UPDATE AND NOTICE OF RESULTS
31st Jul 20203:06 pmRNSTotal Voting Rights
30th Jun 20205:47 pmRNSTotal Voting Rights
9th Jun 20201:10 pmRNSResult of AGM
9th Jun 20207:00 amRNSAGM Statement and Trading Update
1st Jun 202010:25 amRNSTotal Voting Rights
22nd May 20209:35 amRNSBlock Listing Six Monthly Return
13th May 202012:50 pmRNSDirector/PDMR Shareholding
6th May 20202:00 pmRNSAnnual Report and Accounts
1st May 20207:00 amRNSTotal Voting Rights
15th Apr 20204:55 pmRNSBlock Listing Application
9th Apr 20204:42 pmRNSSecond Price Monitoring Extn
9th Apr 20204:37 pmRNSPrice Monitoring Extension
8th Apr 20202:04 pmRNSPreliminary Results: Replacement
8th Apr 20207:00 amRNSPreliminary Results
6th Apr 20207:00 amRNSNotice of Results
23rd Mar 20207:00 amRNSDelay to Publication of Full Year Results
17th Mar 20204:40 pmRNSSecond Price Monitoring Extn
17th Mar 20204:36 pmRNSPrice Monitoring Extension
20th Feb 20204:41 pmRNSSecond Price Monitoring Extn
20th Feb 20204:36 pmRNSPrice Monitoring Extension
11th Feb 20207:00 amRNSTrading Statement and Notice of Results
7th Jan 20203:19 pmRNSExercise and Sale of Options, Total Voting Rights
18th Dec 20195:40 pmRNSExercise and Sale of Options, Total Voting Rights
10th Dec 20197:00 amRNSTrading Statement
2nd Dec 20192:42 pmRNSBlock listing Six Monthly Return
23rd Oct 20193:38 pmRNSExercise and Sale of Options & Total Voting Rights
22nd Oct 20192:00 pmRNSExercise and Sale of Options & Total Voting Rights
17th Oct 20194:55 pmRNSExercise of Options and Total Voting Rights
24th Sep 20197:01 amRNSAppointment by Advantage Finance of New CEO
24th Sep 20197:00 amRNSInterim Results
15th Aug 201912:08 pmRNSSecond Price Monitoring Extn
15th Aug 201912:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.